Dr. Christopher Andrews joins M Pharmaceutical board

Christopher Andrews, MD, MSc, FRCPC, a gastroenterologist with the University of Calgary in Canada, has joined the M Pharmaceutical board of directors.

Advertisement

M Pharmaceutical is focused on developing biomedical technologies for obesity and diabetes.

Dr. Andrews focuses on stomach disorders and physiology. He completed advanced training in GI motility and function, as well as a master’s degree in clinical health research, at Mayo Clinic in Rochester, Minn.

More articles on gastroenterology:
Commonwealth Laboratories launches IBS blood test
Global capsule endoscopy market to grow at 11% until 2019: 4 key trends
18k Stretta procedures performed since its introduction

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.